Cite
HARVARD Citation
Milioli, H. et al. (2020). Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets. Endocrine-related cancer. 27 (5), pp. R93-R112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Milioli, H. et al. (2020). Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets. Endocrine-related cancer. 27 (5), pp. R93-R112. [Online].